Association of BRCA1/2, homologous recombination deficiency, and PD-L1 with clinical outcomes in patients receiving atezolizumab versus placebo combined with carboplatin, paclitaxel, and bevacizumab for newly diagnosed ovarian cancer: Exploratory analyses of IMagyn050/GOG3015/ENGOT-ov39 Meeting Abstract
| Authors: | Landen, C.; Molinero, L.; Sehouli, J.; Miller, A.; Moore, K.; Taskiran, C.; Bookman, M.; Lindemann, K.; Anderson, C.; Berger, R.; Myers, T.; Beiner, M.; Reid, T.; Van Nieuwenhuysen, E.; Green, A.; Okamoto, A.; Aghajanian, C.; Thaker, P.; Blank, S.; Khor, V.; Wu, F.; Lin, Y.; Pignata, S. |
| Abstract Title: | Association of BRCA1/2, homologous recombination deficiency, and PD-L1 with clinical outcomes in patients receiving atezolizumab versus placebo combined with carboplatin, paclitaxel, and bevacizumab for newly diagnosed ovarian cancer: Exploratory analyses of IMagyn050/GOG3015/ENGOT-ov39 |
| Meeting Title: | 2021 Society of Gynecologic Oncology - 52nd Annual Meeting on Women's Cancer |
| Journal Title: | Gynecologic Oncology |
| Volume: | 162 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Mar 19-25 |
| Meeting Location: | Virtual |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-08-01 |
| Start Page: | S37 |
| End Page: | S38 |
| Language: | English |
| ACCESSION: | WOS:000687070800062 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0090-8258(21)00716-2 |
| Notes: | Meeting Abstract: 62 -- Source: Wos |
